Interactions between human leukocyte antigens (HLAs) and peptides play a critical role 1 in the human immune system. Accurate computational prediction of HLA-binding 2 peptides can be used for peptide drug discovery. Currently, the best prediction 3 algorithms are neural network based pan-specific models, which take advantage of the 4 large amount of data across HLA alleles. However, current pan-specific models are all 5 based on the pseudo sequence encoding for modeling the binding context and depend on 6 the available HLA protein-peptide bound structures. In this work, we proposed a novel 7 deep convolutional neural network model (DCNN) for HLA-peptide binding prediction, 8 in which the encoding of the HLA sequence and the binding context are both learned by 9 the network itself without requiring the HLA-peptide bound structure information. Our 10 DCNN model is also characterized by its binding context extraction layer and dual 11 outputs with both binding affinity output and binding probability outputs. Evaluation 12 on public benchmark datasets shows that our DeepSeqPan model without HLA 13 structural information in training achieves state-of-the-art performance on a large 14 number of HLA alleles with good generalization capability. Since our model only needs 15 raw sequences from the HLA-peptide binding pairs, it can be applied to binding 16 predictions of HLAs without structure information and can also be applied to other 17 protein binding problems such as protein-DNA and protein-RNA bindings. The 18 implementation code and trained models are freely available at 19 https://github.com/pcpLiu/DeepSeqPan.
Introduction 21
Human leukocyte antigens (HLAs) are major histocompatibility complex (MHC) 22 proteins located on the cell surface in human. HLAs play a critical role helping our 23 immune system recognizing pathogens by binding to peptide fragments derived from 24 pathogens and exposing them on the cell surface for recognition by appropriate T cells. 25 Study of the binding mechanism between peptides and HLAs can help improve our 26 understanding of human immune system and boost the development of protein-based 27 vaccines and drugs [12, 13] . Out of all classes of HLAs, we are interested in two major 28 classes: class I and II. Class-I HLAs bind to peptides inside the cell while class-II HLAs 29 bind to peptides outside the cell. entry is characterized by nine pairs, where each pair consists of a list of pocket amino 82 acids and a specificity vector. 83 Deep convolutional neural networks (DCNN) are powerful deep learning models and 84 have been successfully applied in many bioinformatics problems such as DNA-binding 85 prediction and CpG island binding prediction [1, 2] . This technique has also been 86 applied to peptide-MHC binding prediction [4, 7, 23] . Among them, Kim et al. proposed 87 a pan-specific DCNN model for peptide-MHC class I binding prediction [4] , in which the 88 peptide-binding context is encoded using NetMHCPan's contact residue sequence 89 method and the DCNN model is trained as a 26-layer classifier. 90 To our best knowledge, the pseudo sequence encoding proposed in NetMHCPan is 91 currently the only binding context encoding method in pan-specific peptide-HLA class I 92 binding prediction, which has achieved state-of-the-art performance in the public 93 benchmark study [22] . However, this encoding method has its potential limitations: 1) 94 its interaction map extraction step relies on available MHC-peptide bound complex 95 structures, which may not be always available, especially considering the high 96 polymorphism of HLA proteins; 2) the 34 contact residues of the encoding is empirical 97 and only covers part of the whole HLA sequence. 98 In this paper, we propose DeepSeqPan (Figure 2) , an end-to-end deep learning 99 model trained on pairs of one-hot encoded raw peptides and HLA sequences, which 100 make it possible to train pan-specific HLA-peptide binding prediction model without 101 the three dimensional structural data. Evaluation on the independent IEDB benchmark 102 datasets showed that our proposed model achieved highly competitive performance on 103 many HLA alleles. Our contributions can be summarized as follows: 2018-01-26 3 . To address the concern that duplicate peptides may exist in both the 117 training and testing data downloaded from IEDB, we removed all duplicate peptides 118 from the testing dataset. The aligned HLA sequences were obtained from IMGT/HLA 119 database [19] . We trained our model on 9-length peptides binding to HLA-A, HLA-B 
Height (1) Width (9) Channel (20) Amino acid channels Figure 3 . Peptide encoding example. Sequence HLNPNKTKR is encoded into a 2D tensor with dimension 1(height) × 9(width) × 20(channel). Each of 20 channels represents one amino acid type and we set a channel value to 1 if the corresponding amino acid appears at this location of the input sequence.
The deep neural network model of DeepSeqPan
135
Architecture As shown in Figure 2 , the DeepSeqPan network consists of three parts: 136 (i) Peptide and HLA encoders. The peptide and HLA encoders convert a pair 137 of one-hot encoded peptide and HLA sequences into two tensors with a unified 138 dimension 1 × 9 × 10. The output tensors of two encoders are concatenated along 139 the channel axis to generate an encoded feature tensor with dimension 1 × 9 × 20. 140 Then this concatenated tensor will be fed into the binding context extractor in (ii). 141 The purpose of these two encoders is extracting high-level features from raw 142 sequences and encoding them into a feature tensor. Different from the 34 pseudo 143 amino acid sequence encoding approach in [14] , the features and information 144 stored inside this feature tensor are learned by the deep neural network 145 automatically with its end-to-end training framework. The encoder of the peptide 146 consists of two blocks of convolutional, batch normalization and LeakyReLu layers. 147 As for the HLA encoder whose input sequence is much longer than the peptide, 148 we used a network configuration similar to the VGG network [20] . feature tensor with length 9, an extracted feature A located at position 1 should 159 have different effect as it appears at position 7. Locally connected layers has the 160 capability to capture features at specific locations since its filters at different 161 locations do not share weights, which has been proved to be powerful in 162 DeepFace [21] . relationship in order to reduce the total loss. In that case, we argue that the 178 classification predictor plays as a regularizer by forcing the network to predict a 179 more accurate IC 50 values. 180 We went through a grid search over hyperparameters setting and the detailed 181 configurations of the layers/blocks and associated hyperparameters are described in the 182 Supplementary File.
183
Loss Function. The overall loss L is the sum of the regression loss L R and the 184 classification loss L C as illustrated in Equation (1).
For IC 50 predictor, we use mean squared error (MSE, Equation (2)) as the loss function 186 and for the binary binding predictor, the binary cross entropy loss (Equation (3)) is 187 used.
To get binary binding labels, we use standard 500 nM threshold to convert a IC 50 value 189 label into a binding label:
Training. We randomly split all training samples into a training set and a validation 191 set following 4:1 ratio. Stochastic gradient descent (SGD) is employed as the website [22] .
202
In pan-specific binding prediction modeling, the IC 50 values of the peptides span a 203 large range [0, 80000]. To avoid gradient explosion issue in neural network training, we 204 convert IC 50 to logIC 50 via Equation 5. The logIC 50 are then used as labels during 205 training. During inference stage, we convert the prediction results back to IC 50 values. 206 logIC 50 = log e IC 50 (5) Results and discussion We trained a single DeepSeqPan model on all 9-length peptides in the training 228 dataset that bind to HLA-A, -B and -C alleles. Then this trained model was evaluated 229 on all available IEDB weekly benchmark dataset [22] . As we inform before, the IEDB 230 7/15 benchmark dataset has been filtered by removing duplicate samples. We compared the 231 performance of DeepSeqPan with those of pan-specific models: NetMHCPan(2.8) [6] 232 and PickPocket [25] , the performances of allele-specific models: SMM [17] , 233 NetMHC(3.4) [12] , ARB [22] , MHCflurry [16] and AMMPMBEC [22] , and those of 234 ensemble models (results are based on several different models): IEDB Consensus [22] 235 and NetMHCcons [9] . All the prediction results of compared models in Table 2 First we compared the performance of DeepSeqPan with other pan-specific models 244 and ensemble model based on pan-specific models. We found that DeepSeqPan showed 245 highly competitive performance by achieving the highest AUC scores in 19 datasets out 246 of total 64 testing datasets. This is only second to NetMHCPan, which outperforms 247 others in 23 datasets and uses structural information of HLA-peptide complex structure 248 information. However, in 45 datasets that DeepSeqPan didn't achieve the highest AUC 249 scores, there are 28 datasets on which the AUC scores of DeepSeqPan are very close to 250 the highest AUC scores within a small margin around 0.1. Our algorithm also 251 outperforms another pan-specific model, PickPocket, which has the highest AUC scores 252 over 10 datasets. Our method also beats the best ensemble method NetMHCcons with 253 the best performance on 16 datasets, which is based on fusion of NetMHC, NetMHCPan 254 and PickPocket [9] . In terms of SRCC, DeepSeqPan obtained the highest scores on 13 255 datasets compared to 21 of NetMHCPan, 16 of NetMHCcons, and 14 of NetMHC.
256
Overall, the benchmark evaluation results showed that DeepSeqPan is highly 257 competitive in HLA-peptide binding prediction with 2nd most highest AUC scores and 258 4th highest SRCC scores. This is impressive considering that our model was trained 259 only on raw amino acid sequence without relying on any structure or amino acid 260 properties information. From Table 2 , it can be found that different pan-specific and 261 allele-specific methods have the best performance on datasets of various alleles, which 262 implies the good performance of the ensemble methods such as NetMHCcons since they 263 make prediction via combining results from multiple methods. Our proposed 264 DeepSeqPan could thus be a complementary tool for existing pan-specific models and it 265 is promising to include it into the state-of-the-art ensemble prediction models to 266 improved their performance. with ours obtained in previous benchmark evaluation and the binary prediction outputs 281 were used to compare. Since Kim's model was trained as a classifier, we calculated AUC 282 scores for each testing dataset and in Table 3 we showed the average AUC scores HLA-C samples in its training data (so it is blind to the test samples that binds HLA-C). 300 Then we predicted the binding of the peptide samples that bind to HLA-C alleles with 301 this trained Blind model. All samples are taken from the training dataset (i.e. BD2013) 302 such that we can compare this model's performance with that of 5-fold cross-validation. 303 The comparison results are shown in Table 4 . end-to-end learning framework of the DCNN is predictor-independent and has captured 360 information related to HLA-peptide binding. Its effectiveness in HLA binding prediction 361 may be explained by its capability to capture position related information such as when 362 there's an animo acid A in HLA at position 37 and at the same time there's an amino 363 acid L in peptide at position 5, the binding affinity is high. This binding feature 364 extraction is similar to DCNN architectures like VGG16 [20] , ResNet [5] of computer 365 vision in which an input image will be represented as a high-dimension vector (4096 in 366 VGG16 and 1000 in ResNet) in the final stage of the neural network. Due to time and 367 hardware resource constraints, our current version of DeepSeqPan only uses one-hot 368 encoding information. No other information such as physical properties of amino acids 369 are encoded into input tensors, which however can further improve the performance of 370 DeepSeqPan if properly encoded by capturing more relevant and rich binding contexts. 371 In this work, we designed, DeepSeqPan, a novel deep convolutional neural network 373 model for pan-specific HLA-peptide binding affinity prediction. This model is 374 characterized by its capability of binding prediction with only the raw amino acid 375 sequences of the peptide and the HLA, which makes it applicable to HLA-peptide 376 binding prediction for HLA alleles without structural information. This is achieved by a 377 novel sequence based encoding of the peptide-HLA binding context, a binding context 378 feature extractor, and the dual outputs with both binding affinity and binding 379 probability predictions. Extensive evaluation of DeepSeqPan on public benchmark 380 experiments showed that our model achieves state-of-the-art performance on an variety 381 of HLA allele datasets.
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Our model contributes to the study of MHC-peptide binding prediction in a few 383 special ways. First, our experiments showed that it is possible to extrapolate the 384 binding prediction capability to unseen HLA alleles, which is important for pan-specific 385 models. Second, our sequence-only based binding context encoding is complementary to 386 to the pseudo sequence encoding, which is currently the only encoding method used in 387 pan-specific models for class I MHC-peptide binding affinity prediction. This has the 388 potential to further improve the state-of-the-art prediction models such as the 389 pan-specific model NetMHCSpan. It showed the importance of sufficient amount of 390 training data to achieve high prediction performance for deep learning models.
391
Our current work can be further improved in a number of ways. First, in this work, 392 only one-hot encoding is used for representing the input peptide and HLA protein. 
